Literature DB >> 18774906

High prevalence of low high-density lipoprotein cholesterol concentrations and other dyslipidemic phenotypes in an Iranian population.

F Sharifi1, S N Mousavinasab, R Soruri, M Saeini, M Dinmohammadi.   

Abstract

OBJECTIVE: This study was designed to determine the prevalence of different atherogenic dyslipidemic phenotypes, especially decreased serum high-density lipoprotein cholesterol (HDL-C) in an Iranian population and its relationship to other coronary artery disease (CAD) risk factor.
METHODS: The prevalence of lipid abnormalities was assessed in 2941 people, including 1396 males and 1545 females, aged more than 20 years. The population is representative of Iranian urban adults living in northwestern Iran. In addition to isolated forms of hypertriglyceridemia, hypercholesterolemia, and hypoalphalipoproteinemia, some dyslipidemic phenotypes including hypertriglyceridemia/low high-density lipoprotein (HDL) combination, mixed dyslipidemias, and severe dyslipidemias were assessed.
RESULTS: The most prevalent abnormality was low HDL cholesterol (HDL-C; 73% including 63% for men and 93.3% for women). Hypertriglyceridemia (>150 mg/dL) was the second most prevalent abnormality (40.6%). Increased total cholesterol (>200 mg/dL) was observed in 35.4% of the subjects. The combination of hypertriglyceridemia and low HDL-C was observed in 9.9% of the population. Fifty eight percent of the low HDL-C cases were not accompanied with hypertriglyceridemia, and 24.4% of hypertriglyceridemic subjects had low HDL-C. Among subjects younger than 30 years, 19% had hypercholesterolemia, 13% had isolated low HDL-C less than 35 mg/dL, and 63% had HDL-C less than 40 mg/dL. Unexpectedly, except for the hypertriglyceridemia/low HDL-C pattern, which was more common in males, the other abnormal lipid profiles were more common in females.
CONCLUSION: The prevalence of dyslipidemia, especially low HDL cholesterol, in Iranian adults is very high. Urgent preventive programs and changes in lifestyle are needed in this area.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18774906     DOI: 10.1089/met.2008.0007

Source DB:  PubMed          Journal:  Metab Syndr Relat Disord        ISSN: 1540-4196            Impact factor:   1.894


  16 in total

1.  Ethnic Variation in Lipid Profile and Its Associations with Body Composition and Diet: Differences Between Iranians, Indians and Caucasians Living in Australia.

Authors:  Majid Meshkini; Fariba Alaei-Shahmiri; Cyril Mamotte; Jaya Earnest
Journal:  J Immigr Minor Health       Date:  2017-02

2.  High prevalence of low HDL-c in the Philippines compared to the US: population differences in associations with diet and BMI.

Authors:  Julienne N Rutherford; Thomas W McDade; Alan B Feranil; Linda S Adair; Christopher W Kuzawa
Journal:  Asia Pac J Clin Nutr       Date:  2010       Impact factor: 1.662

3.  Lipid Profiles and Hepatitis C Viral Markers in HCV-Infected Thalassemic Patients.

Authors:  Seyed-Moayed Alavian; Seyyed Mohammad Miri; Seyed-Vahid Tabatabaei; Maryam Keshvari; Bita Behnava; Pegah Karimi Elizee; Nastaran Mahboobi; Kamran Bagheri Lankarani
Journal:  Gut Liver       Date:  2011-08-18       Impact factor: 4.519

4.  Prevalence of metabolic syndrome in bus and truck drivers in Kashan, Iran.

Authors:  Hamid R Saberi; Ali R Moravveji; Esmaeil Fakharian; Masoud Motalebi Kashani; Ali R Dehdashti
Journal:  Diabetol Metab Syndr       Date:  2011-05-19       Impact factor: 3.320

5.  Impact of lipid disorders on mortality among Saudi patients with heart failure.

Authors:  M Al Qahtani; T Al Backer; T Al Anazi; N Al Johani; S Binsalih; M AlGobain; H Alshammari
Journal:  J Saudi Heart Assoc       Date:  2014-12-23

6.  Serum HDL-C level of Iranian adults: results from sixth national Surveillance of Risk Factors of Non-Communicable Disease.

Authors:  Mostafa Hosseini; Iman Navidi; Mahmoud Yousefifard; Ramin Heshmat; Jalil Koohpayehzadeh; Fereshteh Asgari; Koorosh Etemad; Ali Rafei; Mohammad Mehdi Gouya
Journal:  J Diabetes Metab Disord       Date:  2014-06-16

7.  Prevalence of metabolic syndrome in an adult urban population of the west of Iran.

Authors:  F Sharifi; S N Mousavinasab; M Saeini; M Dinmohammadi
Journal:  Exp Diabetes Res       Date:  2009-11-04

Review 8.  Coronary artery disease and its risk factors status in iran: a review.

Authors:  M Ebrahimi; S M R Kazemi-Bajestani; M Ghayour-Mobarhan; G A A Ferns
Journal:  Iran Red Crescent Med J       Date:  2011-09-15       Impact factor: 0.611

Review 9.  Prevalence of dyslipidemia in iran: a systematic review and meta-analysis study.

Authors:  Ozra Tabatabaei-Malazy; Mostafa Qorbani; Tahereh Samavat; Farshad Sharifi; Bagher Larijani; Hossein Fakhrzadeh
Journal:  Int J Prev Med       Date:  2014-04

10.  The Prevalence of Cardiovascular Disease Risk Factors among Employees in the Kingdom of Bahrain between October 2010 and March 2011: A Cross-Sectional Study from a Workplace Health Campaign.

Authors:  Ameera Ali Al-Nooh; Abdulhussain Abdulabbas Abdulla Alajmi; David Wood
Journal:  Cardiol Res Pract       Date:  2014-07-06       Impact factor: 1.866

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.